Sustained response off-treatment to entecavir and lamivudine after 48 weeks of treatment in nucleoside-naive, HBEAG(+) patients: 24-week follow-up results of phase 3 study ETV-022
JOURNAL OF HEPATOLOGY（2005）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要